Pharmaceutical companies OEM New Trends.doc

 PAGE \* MERGEFORMAT 13 Pharmaceutical companies OEM New Trends October 13, was once the Far East’s largest pharmaceutical companies in Shanghai sine laboratory officially announced, the plant has been approved in the state-owned pharmaceutical enterprises in the first one in line with the U.S. FDA and EU CGMP standards of solid dosage manufacturing base, with a total investment in the 2 billion yuan. The production base is designed to produce up to 5 billion, in addition to producing its own sine of the medicines listed on European and American markets, while European and American markets can be listed on the OEM production of drugs. Looking at the height of the domestic pharmaceutical production lines idle and the pharmaceutical industry, foreign investment in the enthusiasm of this high, and drug distribution trade enterprises to the extension of the upstream part of the various pharmaceutical impulse, similar to the sine medicine such as OEM plans mean ‘after GMP Times’ drugs party processing of a new wave coming? And circulation enterprises OEM impulse ‘In fact, the drug commission processing has long been in existence, but drug sales pharmaceutical distribution enterprise or natural person, the production has been commissioned by pharmaceutical companies accounted for the largest share of commissioned processing’. Mainly engaged in pharmaceutical trade, business, chairman of Shenzhen Comfort Industrial Co., Ltd. Tang Weiming told the reporter: ‘the past, some drug commission process is covert, such as the South China coast has been sly for the Hong Kong pharmaceutical processing products, do not have to go through any procedures. As the pharmaceutical industry norms, as well as GMP pharmaceutical equipment off after the rise in the rate, drug commission processing business will be more heat, which extends upward flow of the company’s enthusiasm will continue to rise. ‘ , General manager of a pharmaceutical trading enterprises in Henan told reporters